002435 ST长江健康
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)-0.270-18.4841.438-8.6224.960
总资产报酬率 ROA (%)-0.117-9.5090.894-5.7703.664
投入资产回报率 ROIC (%)-0.125-10.2720.981-6.2683.766

边际利润分析
销售毛利率 (%)26.33333.35633.42144.11556.295
营业利润率 (%)-1.348-24.2032.466-12.5437.381
息税前利润/营业总收入 (%)2.014-21.4313.932-7.8778.145
净利润/营业总收入 (%)-2.451-24.9521.191-9.5165.750

收益指标分析
经营活动净收益/利润总额(%)135.36218.922107.090-42.41792.216
价值变动净收益/利润总额(%)-30.9350.9040.342-2.975-0.533
营业外收支净额/利润总额(%)1.870-0.007-28.889-34.614-7.550

偿债能力分析
流动比率 (X)1.2501.2571.6512.0832.203
速动比率 (X)1.1171.1191.3791.6281.806
资产负债率 (%)56.19256.76437.24635.74728.527
带息债务/全部投入资本 (%)48.76949.33128.55024.748--
股东权益/带息债务 (%)95.14693.791232.904282.784346.081
股东权益/负债合计 (%)77.28675.387165.452175.538249.291
利息保障倍数 (X)0.594-7.7371.948-5.4666.353

营运能力分析
应收账款周转天数 (天)36.67930.22133.07230.7250.000
存货周转天数 (天)104.12799.304115.731109.3260.000